Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Original Research
Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,946 | Dovepress* | 4,554+ | 874 | 5,428 | |
| PubMed Central* | 392 | 175 | 567 | ||
| Totals | 4,946 | 1,049 | 5,995 | ||
| *Since 28 February 2019 | |||||
View citations on PubMed Central and Google Scholar